StockData
Faeth Therapeutics, Inc. logo

Faeth Therapeutics, Inc. (FTH) bonds

FTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30
$10.03−0.62 (-5.82%)

Close on Nov 13, 2026Market cap $259.18MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Faeth Therapeutics reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Faeth Therapeutics's 10-K for the period ended Aug 6, 2021

IssueCouponAmount issued
PPP Loan1.00%$567.00K

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K.

See a number that looks wrong?